Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2005-01-25
2005-01-25
Ketter, James (Department: 1636)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S029000
Reexamination Certificate
active
06846627
ABSTRACT:
Disclosed is a process for identifying compounds having a specified activity of interest, which process comprises (i) introducing interacting molecules into a host cell under conditions to generate or repress a detectable signal; and (ii) introducing a third compound or gene or genes encoding a third compound into the host cell from (i); and (iii) screening said host cell utilizing a method for detecting the inhibition or enhancement of interaction of proteins or other molecules in an in vivo or in vitro system. Another aspect of the present invention provides a process for identifying compounds of interest, which process comprises (i) generating one or more expression libraries derived from nucleic acid directly isolated from the environment; and (ii) screening said libraries utilizing a method for detecting the inhibition or enhancement of interaction of proteins or other molecules in an in vivo or in vitro system.
REFERENCES:
patent: 5322801 (1994-06-01), Kingston et al.
patent: 5525490 (1996-06-01), Erickson et al.
patent: 5569588 (1996-10-01), Ashby et al.
patent: 5582995 (1996-12-01), Avruch et al.
patent: WO 9409133 (1994-04-01), None
patent: WO 9528497 (1995-10-01), None
patent: WO 9534646 (1995-12-01), None
patent: WO 9704077 (1997-02-01), None
Patanjuli et al (1991) Proc. Natl. Acad. Sci. 88:1943-1947.*
Mendelsohn et al (1995) Curr. Op. in Biotech. 5:482-486.*
Horikoshi (1995) Curr. Op. in Biotech. 6:292-297.*
Stein et al (1996) J. Bact. 178:591-599.*
Chaudhuri et al., “The interaction between the catalytic A subunit of calcineurin and its autoinhibitory domain, in the yeast two-hybrid system, is disrupted by cyclosporin A and FK506,”Federation of European Biochemical Societies357:221-226 (1995).
Chiu et al., “RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12/rapamycin complex,”Proc. Natl. Acad. Sci. USA91:12574-12578 (Dec. 1994).
Mendelsohn and Brent, “Applications of interaction traps/two-hybrid systems to biotechnology research,”Current Opinion in Biotechnology5:482-486 (1994).
Vidal et al., “Reverse two-hybrid and one-hybrid systems to detect dissociation of protei—protein and DNA-protein and interactions,”Proc. Natl. Acad. Sci. USA93:10315-10320 (Sep. 1996).
Yang et al., “Cyclophilin A and FKBP12 Interact with YY12 and Alter Its Transcriptional Activity,”The Journal of BiologicalChemistry270(28):15187-15193 (Jun. 1996).
Diversa Corporation
Gary Cary Ware & Freidenrich LLP
Ketter James
LandOfFree
Screening for novel compounds which regulate biological... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Screening for novel compounds which regulate biological..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Screening for novel compounds which regulate biological... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3369465